Docstoc

2012 Aarkstore.com | H. Lundbeck A/S – Product Pipeline Review – 2012

Document Sample
2012 Aarkstore.com | H. Lundbeck A/S – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

H. Lundbeck A/S – Product Pipeline Review – 2012


You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Market Direct’s pharmaceuticals report, “H. Lundbeck A/S - Product Pipeline
Review - 2012” provides data on the H. Lundbeck A/S’s research and development
focus. The report includes information on current developmental pipeline, complete
with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, H. Lundbeck A/S’s corporate website, SEC filings, investor
presentations and featured press releases, both from H. Lundbeck A/S and industry-
specific third party sources, put together by Global Markets Direct’s team.

Scope

- H. Lundbeck A/S - Brief H. Lundbeck A/S overview including business description,
key information and facts, and its locations and subsidiaries.
- Review of current pipeline of H. Lundbeck A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 6
List of Figures 8
H. Lundbeck A/S Snapshot 9
H. Lundbeck A/S Overview 9
Key Information 9
Key Facts 9
H. Lundbeck A/S – Research and Development Overview 10
Key Therapeutic Areas 10
H. Lundbeck A/S – Pipeline Review 13
Pipeline Products by Stage of Development 13
Pipeline Products – Monotherapy 14
H. Lundbeck A/S – Pipeline Products Glance 15
H. Lundbeck A/S – Late Stage Pipeline 15
Registration Filed Products/Combination Treatment Modalities 15
Phase III Products/Combination Treatment Modalities 16
H. Lundbeck A/S Clinical Stage Pipeline Products 17
Phase II Products/Combination Treatment Modalities 17
Phase I Products/Combination Treatment Modalities 18
H. Lundbeck A/S – Early Stage Pipeline Products 19
Pre-Clinical Products/Combination Treatment Modalities 19
H. Lundbeck A/S – Drug Profiles 20
Carbamazepine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Desmoteplase 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
KW-6356 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Lu AA21004 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Lu AA24530 27
Product Description 27
Mechanism of Action 27
List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1




Daiichi Sankyo Company, Limited – Product Pipeline Review – 2012

endreon Corporation – Product Pipeline Review – 2012

Elan Corporation, plc – Product Pipeline Review – 2012

Emisphere Technologies, Inc. – Product Pipeline Review – 2012

H. Lundbeck A/S – Product Pipeline Review – 2012

Baxter International Inc. – Product Pipeline Review – 2012

BioCryst Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Columbia Laboratories Inc. – Product Pipeline Review – 2012

Corcept Therapeutics Incorporated – Product Pipeline Review – 2012

Curis, Inc. – Product Pipeline Review – 2012
Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:9
posted:8/30/2012
language:English
pages:4
Description: This report is built using data and information sourced from Global Markets Direct’s proprietary databases, H. Lundbeck A/S’s corporate website, SEC filings, investor presentations and featured press releases, both from H. Lundbeck A/S and industry-specific third party sources, put together by Global Markets Direct’s team.